Improved Diversion Detection Among the Features That Mark the First Pandora Pharmacy Analytics Product Introduced Since the Acquisition of Pandora by Omnicell
MOUNTAIN VIEW, Calif., Dec. 1, 2010 /PRNewswire/ -- Omnicell, Inc., (Nasdaq: OMCL) a leading provider of medication management solutions to acute healthcare facilities, today announced the introduction of PandoraVIA™ 2.0 pharmacy analytics software. The enhanced software includes improved detection of medication diversion, customizable user options and new hospital inventory management controls among other features designed to assist hospitals in their efforts to improve patient safety and regulatory compliance in hospitals. PandoraVIA 2.0 will be on display at the 45th American Society for Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition in Anaheim, CA.
"The launch of PandoraVIA 2.0 represents the strong results achievable when you combine talent from two great organizations," said Marga Ortigas-Wedekind, Omnicell vice president, global marketing and product development. "The product provides cutting edge reporting and analytics on patient safety and regulatory compliance with a very user-friendly interface."
PandoraVIA 2.0 introduces new features such as virtualization, customizable widgets to quickly monitor drug diversions, inventory management with compliance safety assurances and simplified search functionality. PandoraVIA 2.0 is an interoperable platform that currently integrates with Omnicell, Cerner, Carefusion, McKesson, MedDispense and PatientSafe Solutions Inc. (formerly known as IntelliDOT).
In October 2010, Omnicell acquired Pandora Data Systems, the pharmacy analytics platform sold to over 800 customers for drug diversion detection, inventory management, compliance reporting and point-of-care data analytics. PandoraVIA 2.0 joins the Omnicell business analytics suite of products, which also include Executive Advisor and Medication Surveillance that analyze clinical metrics and present actionable data reports for hospital executives and clinicians.
PandoraVIA 2.0 will be demonstrated at the PandoraVIA exhibit in booth #1953 and at the Omnicell booth #1441 at the ASHP 2010 Midyear conference in Anaheim, CA from December 6-8, 2010. PandoraVIA 2.0 will be available for implementation in January 2011.
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems to enable healthcare facilities to increase operational efficiency, enhance patient safety and allow clinicians to spend more time with their patients.
Founded in 1992, Omnicell's medication-use solutions include complete automation systems for the central pharmacy, anesthesia workstations for the operating room, dispensing cabinet systems for nursing units, and safe, secure medication transportation and verification systems to the patient bedside. From a medication's arrival at the receiving dock to its dosing to the patient, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.
Omnicell supply product lines provide a healthcare institution with comprehensive supply chain solutions that result in fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab and operating room.
For more information, visit www.omnicell.com.
OMCL - G
SOURCE Omnicell, Inc.